Anti-JC virus antibodies: Implications for PML Risk Stratification

Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians

(2010) A. Antonsson et al.   JOURNAL OF GENERAL VIROLOGY

Characterization of JC human polyomavirus infection in a Portuguese population

(2010) Ana Matos et al.   JOURNAL OF MEDICAL VIROLOGY

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

(2010) David B Clifford et al.   LANCET NEUROLOGY

Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies

(2009) Eugene O. Major   Annual Review of Medicine

Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors

(2009) Adrian Egli et al.   JOURNAL OF INFECTIOUS DISEASES

Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients

(2009) Mary K. Grabowski et al.   JOURNAL OF MEDICAL VIROLOGY

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab

(2009) Yiping Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy

(2009) Hans Lindå et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adaptive Mutations in the JC Virus Protein Capsid Are Associated with Progressive Multifocal Leukoencephalopathy (PML)

(2009) Shamil R. Sunyaev et al.   PLoS Genetics

Seroepidemiology of Human Polyomaviruses

(2009) Jaime M. Kean et al.   PLoS Pathogens

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?

(2008) J Verbeeck et al.   GUT

Progressive Multifocal Leukoencephalopathy and Use of Mycophenolate Mofetil After Kidney Transplantation

(2008) Robert T. Neff et al.   TRANSPLANTATION